Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001140361-11-014431
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-04 16:51:48
Reporting Period:
2011-03-02
Filing Date:
2011-03-04
Filing Date Changed:
2011-03-04
Accepted Time:
2011-03-04 16:51:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388111 Rajiv Malik 1500 Corporate Drive
Canonsburg PA 15317
Evp & Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-03 6,409 $0.00 96,691 No 4 M Direct
Common Stock Disposition 2011-03-04 2,065 $22.95 94,626 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option - Right to Buy Acquisiton 2011-03-02 80,264 $0.00 80,264 $22.66
Common Stock Restricted Stock Units Acquisiton 2011-03-02 28,961 $0.00 28,961 $0.00
Common Stock Restricted Stock Units Acquisiton 2011-03-03 6,409 $0.00 6,409 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,264 2021-03-02 No 4 A Direct
28,961 No 4 A Direct
0 No 4 M Direct
Footnotes
  1. Note that the amount of securities beneficially owned has been adjusted to reflect the current transaction as well as a reduction of 10,000 shares to correct an inadvertent overstatement of shares owned reported on a Form 4 filing on February 2, 2010. Each Form 4 filed for this reporting person during the period beginning on February 2, 2010 through July 29, 2010 incorrectly overstated by 10,000 shares the amount of securities beneficially owned following the transaction(s) reported on such Form 4.
  2. Represents the shares sold to cover the tax liability associated with the vesting of a portion of the restricted stock awards (RSUs) granted on March 3, 2010.
  3. These options vest in three equal annual installments beginning on March 2, 2012 and expire March 2, 2021.
  4. Each RSU represents the right to receive one share of Mylan Inc. common stock. The RSUs vest in three equal annual installments beginning on March 2, 2012.
  5. Each RSU represents the right to receive one share of Mylan Inc. common stock. The remainder of this award will vest equally on March 3, 2012 and 2013.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!